1. January 14, 2021

    Flash VIG-News: Metamizole (NOVALGINE): information on risk of liver injury and pharmacokinetic interactions

    Source: FAMHP

    Flash VIG-news: Metamizol (NOVALGINE): informatie over het risico van leverletsel en farmacokinetische interacties

    Flash VIG-news : Métamizole (NOVALGINE) : informations sur les risques de troubles hépatiques et d’interactions pharmacocinétiques

    Read more

  2. January 14, 2021

    Coronavirus: EMA receives application for conditional marketing authorisation for AstraZeneca vaccine

    Source: FAMHP

    Coronavirus: EMA ontvangt aanvraag voor een voorwaardelijke marktvergunning voor vaccin AstraZeneca

    Coronavirus : l'EMA reçoit une demande d'autorisation de mise sur le marché conditionnelle pour le vaccin d’AstraZeneca

    Read more

  3. January 14, 2021

    Flash VIG-news: weekly overview of side effects COVID-19 vaccines

    Source: FAMHP

    Flash VIG-news: wekelijks overzicht bijwerkingen COVID-19-vaccins

    Flash VIG-news : aperçu hebdomadaire des effets indésirables des vaccins contre la COVID-19

    Read more

  4. January 14, 2021

    Coronavirus: sixth dose from vials of Comirnaty vaccine (Pfizer/BioNTech)

    Source: FAMHP

    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended updating the product information for Comirnaty to clarify that each vial contains six doses of the vaccine.

    Read more

  5. January 8, 2021

    Flash VIG-news: weekly overview of side effects COVID-19 vaccines

    Flash VIG-news: wekelijks overzicht bijwerkingen COVID-19-vaccins

    Flash VIG-news : aperçu hebdomadaire des effets indésirables des vaccins contre la COVID-19

    Read more

  6. January 6, 2021

    Corona virus: EMA gives positive opinion for Moderna vaccine

    Source: FAMHP

    Coronavirus: EMA geeft positief advies voor vaccin van Moderna

    Coronavirus : l’EMA émet un avis favorable pour le vaccin de Moderna

    Read more

  7. December 29, 2020

    Coronavirus: EMA organises a second public meeting about the new COVID-19 vaccines

    Source: FAMHP

    The European Medicines Agency (EMA) will organise a second public meeting on 8 January 2021 to inform European citizens about the assessment, approval and roll-out of new COVID-19 vaccines.

    Read more

  8. December 24, 2020

    Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

    Source: FAMHP

    On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have again been extended by one month.

    Read more

  9. December 24, 2020

    Coronavirus: Questions and Answers on COVID-19 vaccines

    Source: FAMHP

    Coronavirus: vragen en antwoorden over de COVID-19-vaccins

    Coronavirus : questions et réponses sur les vaccins contre la COVID-19

    Read more

  10. December 24, 2020

    Coronavirus: new online form to report suspected adverse reactions to a COVID-19 vaccine

    Source: FAMHP

    A new online form now makes it easier to report suspected adverse reactions to a COVID-19 vaccine. The new user-friendly form will also be linked to Vaccinnet+. Therefore, certain fields will be filled in automatically in the future. Reporting adverse reactions can increase the knowledge of the safety profile of the vaccines. The FAMHP will regularly provide an update on the follow-up of the reports.

    Read more